ICC-dementia (International Centenarian Consortium - dementia): an international consortium to determine the prevalence and incidence of dementia in centenarians across diverse ethnoracial and sociocultural groups

Abstract

BackgroundConsiderable variability exists in international prevalence and incidence estimates of dementia. The accuracy of estimates of dementia in the oldest-old and the controversial question of whether dementia incidence and prevalence decline at very old age will be crucial for better understanding the dynamics between survival to extreme old age and the occurrence and risk for various types of dementia and comorbidities. International Centenarian Consortium – Dementia (ICC-Dementia) seeks to harmonise centenarian and near-centenarian studies internationally to describe the cognitive and functional profiles of exceptionally old individuals, and ascertain the trajectories of decline and thereby the age-standardised prevalence and incidence of dementia in this population. The primary goal of the ICC-Dementia is to establish a large and thorough heterogeneous sample that has the power to answer epidemiological questions that small, separate studies cannot. A secondary aim is to examine cohort-specific effects and differential survivorship into very old age. We hope to lay the foundation for further investigation into risk and protective factors for dementia and healthy exceptional brain ageing in centenarians across diverse ethnoracial and sociocultural groups.MethodsStudies focusing on individuals aged ≥95 years (approximately the oldest 1 percentile for men, oldest 5th percentile for women), with a minimum sample of 80 individuals, including assessment of cognition and functional status, are invited to participate. There are currently seventeen member or potential member studies from Asia, Europe, the Americas, and Oceania. Initial attempts at harmonising key variables are in progress.DiscussionGeneral challenges facing large, international consortia like ICC-Dementia include timely and effective communication among member studies, ethical and practical issues relating to human subject studies and data sharing, and the challenges related to data harmonisation. A specific challenge for ICC-Dementia relates to the concept and definition of’abnormal’ in this exceptional group of individuals who are rarely free of physical, sensory and/or cognitive impairments.

Risk of vascular disease and cognitive function in very old adults

“…Although centenarians have been found to have lower rates of some chronic diseases compared with other older adults, several studies have found them to have high rates of cardiovascular disease (Martin et al, 2019) and dementia (Brodaty et al, 2016), thus prompting the research questions raised by Martin et al (2019). There are a number of risk factors for vascular disease of the brain, namely high blood pressure, high cholesterol, diabetes mellitus, coronary artery disease, atrial fibrillation, carotid artery disease, smoking, and inflammation (Bogousslavsky et al, 2000).…”

COVID-19 mortality in Lombardy: the vulnerability of the oldest old and the resilience of male centenarians

“…From 2014 to January 2020 we enrolled, visited and collected data of 130 centenarians, using the annual lists provided by the public health service mentioned above. 90% of our centenarian population are women, but the few males are all in excellent health [ 24 ]. The complex reasons of such a female longevity advantage/paradox is still unclear [ 25 , 26 ] but it is likely the result of a mixture of biological (e.g.…”

A practical computerized decision support system for predicting the severity of Alzheimer’s disease of an individual

“…Numerous studies demonstrated that CDSSs contributed to improving patient safety and care by decreasing the number of therapeutic and diagnostic errors that are unavoidable in human clinical practice (Lindquist, Johansson, Petersson, Saveman, & Nilsson, 2008) and reduced the workload of medical staff, especially in contexts that require frequent monitoring or complex decision-making, such as management of chronic diseases (Wright et al, 2016). Current research directions in dementia, with Alzheimer’s disease (AD) being its most common form, focuses on interventions and treatments that can modify progression of dementia symptoms or lead to an early identification of individuals at risk of developing dementia (Brodaty et al, 2016, Ritchie et al, 2017). Increasing evidence suggests that early diagnosis of dementia can lead to significant clinical and economic benefits.…”